ASH 2023 Profylaxe met emicizumab veelbelovend bij jonge kinderen met ernstige hemofilie A zonder FVIII... Read more
ASH 2023 MRD-status nuttig in besluitvorming rond stamceltransplantatie tijdens eerste complete remissi... Read more
ASH 2023 Nieuwe genetische mutatie ontdekt die tot hematologische maligniteit en beenmergfalen leidt Read more
ASH 2020 Older myeloma patients can safely undergo an autologous stem cell transplantation and achieve ... Read more
ASH 2020 The bispecific antibody mosunetuzumab exhibits promising activity in heavily pretreated non-Ho... Read more
EHA 2019 Frontline brentuximab vedotin + AVD provides durable benefit over ABVD in patients with stage ... Read more
Top
